MNOV vs PATH · rev $123.3K vs P/E 19, rev $1.61B
MediciNova Inc (MNOV) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MNOV revenue for 2025-09-30 was $123.3K. Net income was -$9.2M. Revenue was down 8.4% from 2025-06-30 to 2025-09-30. MNOV currently screens at market cap $66.0M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MNOV currently screens at market cap $66.0M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MNOV and PATH stock pages for the full models.
Not investment advice.